CellaVision AB (CEVI) - Total Liabilities

Latest as of December 2025: Skr207.31 Million SEK ≈ $22.31 Million USD

Based on the latest financial reports, CellaVision AB (CEVI) has total liabilities worth Skr207.31 Million SEK (≈ $22.31 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore CellaVision AB (CEVI) investment intensity to see how much of total assets are deployed in long-term investments.

CellaVision AB - Total Liabilities Trend (2000–2025)

This chart illustrates how CellaVision AB's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see CEVI asset base.

CellaVision AB Competitors by Total Liabilities

The table below lists competitors of CellaVision AB ranked by their total liabilities.

Company	Country	Total Liabilities
Hey-Song Corp TW:1234	Taiwan	NT$5.51 Billion
African Gold Ltd AU:A1G	Australia	AU$3.23 Million
Alexander Marine Co Ltd TW:8478	Taiwan	NT$6.86 Billion
Jiangling Motors Corp Ltd SHE:200550	China	HK$20.49 Billion
Deep Fission, Inc. Common Stock NASDAQ:FISN	USA	$8.55 Million
Chung Hwa Chemical Industrial Works Ltd TW:1727	Taiwan	NT$1.10 Billion
Sichuan Dawn Precision Technology Co Ltd SHE:300780	China	CN¥857.66 Million
Dongwon System KO:014820	Korea	₩701.13 Billion

Liability Composition Analysis (2000–2025)

This chart breaks down CellaVision AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See CellaVision AB (CEVI) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.98	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.23	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.19	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how CellaVision AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for CellaVision AB (2000–2025)

The table below shows the annual total liabilities of CellaVision AB from 2000 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr207.31 Million ≈ $22.31 Million	+5.68%
2024-12-31	Skr196.16 Million ≈ $21.11 Million	-7.61%
2023-12-31	Skr212.32 Million ≈ $22.85 Million	-15.11%
2022-12-31	Skr250.12 Million ≈ $26.92 Million	-11.28%
2021-12-31	Skr281.93 Million ≈ $30.34 Million	+18.26%
2020-12-31	Skr238.41 Million ≈ $25.66 Million	-18.73%
2019-12-31	Skr293.34 Million ≈ $31.57 Million	+255.96%
2018-12-31	Skr82.41 Million ≈ $8.87 Million	+37.93%
2017-12-31	Skr59.75 Million ≈ $6.43 Million	+18.85%
2016-12-31	Skr50.27 Million ≈ $5.41 Million	+36.20%
2015-12-31	Skr36.91 Million ≈ $3.97 Million	-27.56%
2014-12-31	Skr50.95 Million ≈ $5.48 Million	-9.11%
2013-12-31	Skr56.06 Million ≈ $6.03 Million	+4.50%
2012-12-31	Skr53.64 Million ≈ $5.77 Million	+1.87%
2011-12-31	Skr52.66 Million ≈ $5.67 Million	+7.30%
2010-12-31	Skr49.08 Million ≈ $5.28 Million	+27.30%
2009-12-31	Skr38.55 Million ≈ $4.15 Million	-23.64%
2008-12-31	Skr50.49 Million ≈ $5.43 Million	+109.95%
2007-12-31	Skr24.05 Million ≈ $2.59 Million	+1.92%
2006-12-31	Skr23.60 Million ≈ $2.54 Million	+19.90%
2005-12-31	Skr19.68 Million ≈ $2.12 Million	-27.03%
2004-12-31	Skr26.97 Million ≈ $2.90 Million	+20.07%
2003-12-31	Skr22.46 Million ≈ $2.42 Million	-10.24%
2002-12-31	Skr25.02 Million ≈ $2.69 Million	-23.58%
2001-12-31	Skr32.74 Million ≈ $3.52 Million	+79.77%
2000-12-31	Skr18.21 Million ≈ $1.96 Million	--

About CellaVision AB

ST:CEVI Sweden Medical Devices

Market Cap

$418.90 Million

Skr3.89 Billion SEK

Market Cap Rank

#13275 Global

#212 in Sweden

Share Price

Skr163.20

Change (1 day)

-1.09%

52-Week Range

Skr118.40 - Skr188.40

All Time High

Skr478.48